Precision Medicine

Dr. Amie Hornaman's bestseller, The Thyroid Fix, confronts medical gaslighting, empowering women to look beyond 'normal' lab results for answers.

Early human trial data for a new drug, UDP-003, suggests it can safely remove toxic cholesterol, a key step toward reversing arterial plaque buildup.

On May 18, competitors like Ulta and CVS join forces for National Sun Responsibly Day, an urgent call to make daily sun protection a life-saving habit.

With strong HIFU revenue and new clinical trials, EDAP TMS's upcoming Investor Day will reveal its strategy for medtech dominance and investor confidence.

A new partnership integrates Factor's ready-to-eat meals with Berry Street's insured dietitian network, using your meal data to offer personalized advice.

A new partnership aims to solve the massive underdiagnosis of a severe genetic disorder by offering free testing, a move with deep strategic implications.

The Virginia-based startup landed a major funding round to automate liquid biopsy sample prep, aiming to make cancer detection faster and more reliable.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

With a new CEO, a half-billion-dollar war chest, and a novel drug pipeline, Damora Therapeutics is making an aggressive play to redefine blood cancer treatment.

A Belgian firm's new biologic gel for diabetic foot ulcers gets a key FDA green light, offering hope against a leading cause of amputations.

A new specialty clinic in Philadelphia tackles a nationwide shortage of pet dentists, offering advanced, team-based oral care for common animal ailments.

Autoimmune diagnostics firm Exagen reports a 12% revenue jump and improved efficiency, fueling analyst optimism and setting a strong tone for 2026.

Anaveon reveals promising ASCO data for its cancer drug ANV600, yet puts the asset on the market to fund a bold new focus on autoimmune diseases.

OncLive® unveils its 2026 class of inductees, 14 visionaries whose groundbreaking work is transforming the future of oncology and bringing hope to millions.

An innovative RNA-editing therapy for hepatocellular carcinoma has received a major FDA designation, potentially accelerating its path to patients.

As Talphera preps its Q1 update, all eyes are on its breakthrough drug Niyad® and the mounting costs of bringing a potential game-changer to market.

A new AI-powered technology can spot deadly high potassium levels using a simple smartwatch ECG, a breakthrough that could transform remote patient care.

UWorld and the Goldwater Foundation award 93 top students, fueling the pipeline of medical researchers poised to tackle society's biggest health challenges.

A new drug shows major promise for a painful heart condition, with pivotal study results accepted by a top journal and a final-stage trial speeding ahead.

A landmark clinical trial suggests a different form of folate may be better for pregnancy, reducing a controversial byproduct without sacrificing key benefits.